Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Current Deferred Revenue (2018 - 2026)

Alector's (ALEC) quarterly Current Deferred Revenue came in at $6.7 million in Q1 2026, down 69.23% year-over-year from $21.8 million in Q1 2025, and up 0.58% quarter-over-quarter from $6.7 million in Q4 2025.

Analysis

Alector (ALEC) Current Deferred Revenue (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Current Deferred Revenue for 9 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.

  • On a quarterly basis, Current Deferred Revenue fell 69.23% year-over-year to $6.7 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 69.23% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 71.75% from the prior year.
  • Current Deferred Revenue was $6.7 million for Q1 2026 at Alector, up from $6.7 million in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $465.4 million in Q2 2022 and troughed at $6.7 million in Q4 2025.
  • A 5-year average of $130.6 million and a median of $64.0 million in 2024 frame the typical range for Current Deferred Revenue.
  • The widest YoY moves for Current Deferred Revenue: up 282.73% in 2022, down 84.34% in 2022.
  • Over 5 years, Current Deferred Revenue stood at $48.2 million in 2022, then surged by 72.04% to $83.0 million in 2023, then plunged by 71.48% to $23.7 million in 2024, then plunged by 71.75% to $6.7 million in 2025, then grew by 0.58% to $6.7 million in 2026.
  • The last three Current Deferred Revenue figures came in at $6.7 million (Q1 2026), $6.7 million (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn
10 Alector 274.68 Mn 101.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 6.72 Mn
Dec 31, 2025 6.68 Mn
Sep 30, 2025 11.74 Mn
Jun 30, 2025 13.40 Mn
Mar 31, 2025 21.85 Mn
Dec 31, 2024 23.66 Mn
Sep 30, 2024 55.43 Mn
Jun 30, 2024 63.96 Mn
Mar 31, 2024 73.35 Mn
Dec 31, 2023 82.98 Mn
Sep 30, 2023 80.56 Mn
Jun 30, 2023 267.20 Mn
Mar 31, 2023 433.60 Mn
Dec 31, 2022 48.23 Mn
Sep 30, 2022 119.68 Mn
Jun 30, 2022 465.40 Mn
Mar 31, 2022 444.90 Mn
Dec 31, 2021 307.90 Mn
Sep 30, 2021 320.20 Mn
Jun 30, 2021 121.60 Mn